AZN · AstraZeneca Plc
AI read · Good for AZN
The AI's read
These approvals give AstraZeneca new treatment options for people with two serious illnesses, including some patients who cannot take cisplatin. The bladder-cancer study found fewer serious outcomes with the new treatment plan. Klygefa still awaits decisions in China and other countries, limiting its reach there for now.